Valuation: DIAGNOS Inc.

Market Cap 31.31M 22.29M 19.48M 17.97M 16.52M 2.14B 31.84M 215M 84.2M 1.05B 83.69M 81.86M 3.61B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 30.78M 21.91M 19.16M 17.67M 16.25M 2.11B 31.31M 211M 82.79M 1.03B 82.29M 80.49M 3.55B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
95.78%
Yield 2025 *
-
Yield 2026 -
Current month+4.00%
1 month+33.33%
6 months-20.00%
Current year-30.67%
1 week 0.25
Extreme 0.25
0.28
1 month 0.2
Extreme 0.2
0.28
Current year 0.18
Extreme 0.175
0.38
1 year 0.18
Extreme 0.175
0.42
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.6
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2008-04-30
Chief Operating Officer - 2024-01-15
Director TitleAgeSince
Director/Board Member - 2000-09-20
Director/Board Member 72 2020-09-27
Chairman 69 2025-10-29
Date Insider Type Main position Quantity % Market Cap.
06-10Option

Chief Financial Officer

200,000 0.1661%
06-10Option

Chairman

300,000 0.2491%
06-10Option

Director

250,000 0.2076%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+18.18%-50.94% 22.27M
-2.70%-30.08%-25.29%+58.32% 204B
-1.47%+4.04%+27.76%+50.38% 95.64B
+1.83%-0.12%-50.37%-56.61% 82.34B
-0.52%+6.40%-32.69%-37.71% 82.89B
+2.33%+4.25%-37.21%-1.65% 57.7B
-1.52%+0.65%-32.12%-24.52% 46.07B
+3.35%+0.59%+13.54%+219.99% 36.55B
0.00%-5.16%+0.37%+74.51% 36.18B
+0.11%+1.96%-25.43%+1.48% 32.87B
Average +0.30%-1.38%-14.33%+23.32% 67.43B
Weighted average by Cap. -0.36%-7.18%-19.75%+27.42%

Financials

2025 2026
Net sales 104K 73.89K 64.6K 59.59K 54.78K 7.11M 106K 711K 279K 3.48M 277K 271K 11.98M 65.48K 46.61K 40.75K 37.59K 34.56K 4.48M 66.6K 449K 176K 2.19M 175K 171K 7.56M
Net income -4.29M -3.05M -2.67M -2.46M -2.26M -294M -4.36M -29.38M -11.53M -144M -11.46M -11.21M -495M -4.56M -3.24M -2.84M -2.62M -2.4M -312M -4.63M -31.22M -12.25M -153M -12.18M -11.91M -526M
Net Debt -164K -117K -102K -93.99K -86.4K -11.21M -167K -1.12M -440K -5.48M -438K -428K -18.89M -525K -374K -327K -302K -277K -35.97M -534K -3.6M -1.41M -17.58M -1.4M -1.37M -60.6M
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
26-07-15 $0.2600 0.00% 252,300
26-07-14 $0.2600 -1.89% 224,678
26-07-13 $0.2650 -1.85% 246,500
26-07-10 $0.2700 +1.89% 86,769
26-07-09 $0.2650 +1.92% 40,750

Annual profits - Rate of surprise